We are delighted to be featured in the latest issue of VentureCapital Magazine, which spotlights the Dresden region as a high-performance hub for key players and innovators in radiopharmaceutical innovation.
ROTOP Pharmaka is recognized as a leading manufacturer of radiopharmaceuticals, including an iodine-123 compound used in Parkinson’s diagnostics. The article also emphasizes the strong network we are part of – combining research collaborations, advanced manufacturing, and the development of innovative theranostic solutions – and highlights how this ecosystem is driving meaningful progress in patient care.
Original Source: https://bc-production.pressmatrix.com/de/profiles/98d522283e29/editions
Have a look at the VentureCapital Magazine: https://bc-production.pressmatrix.com/de/profiles/98d522283e29/editions/d0f1f2c05ace72a5f55d
Ähnliche Beiträge
ROTOP featured in VentureCapital Magazine
We are delighted to be featured in the latest
New Milestone: RoTecPSMA® Approved in Switzerland
RoTecPSMA® Approved in Switzerland – Expanding Access to Advanced
Team ROTOP is back from SNMMI 2025 in New Orleans
Team ROTOP is back from SNMMI 2025 in New